Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Peptaibol-Containing Extracts of Trichoderma atroviride and the Fight against Resistant Microorganisms and Cancer Cells

J. Víglaš, S. Dobiasová, J. Viktorová, T. Ruml, V. Repiská, P. Olejníková, H. Gbelcová

. 2021 ; 26 (19) : . [pub] 20211004

Language English Country Switzerland

Document type Journal Article

Grant support
VEGA-1/0697/18 Grant Agency of Ministry of Education, Science, Research and Sport of the Slovak Republic
22010090 International Visegrad Fund

Fighting resistance to antibiotics and chemotherapeutics has brought bioactive peptides to the fore. Peptaibols are short α-aminoisobutyric acid-containing peptides produced by Trichoderma species. Here, we studied the production of peptaibols by Trichoderma atroviride O1 and evaluated their antibacterial and anticancer activity against drug-sensitive and multidrug-resistant bacterium and cancer cell lines. This was substantiated by an analysis of the activity of the peptaibol synthetase-encoding gene. Atroviridins, 20-residue peptaibols were detected using MALDI-TOF mass spectrometry. Gram-positive bacteria were susceptible to peptaibol-containing extracts of T. atroviride O1. A synergic effect of extract constituents was possible, and the biolo-gical activity of extracts was pronounced in/after the peak of peptaibol synthetase activity. The growth of methicillin-resistant Staphylococcus aureus was reduced to just under 10% compared to the control. The effect of peptaibol-containing extracts was strongly modulated by the lipoteichoic acid and only slightly by the horse blood serum present in the cultivation medium. Peptaibol-containing extracts affected the proliferation of human breast cancer and human ovarian cancer cell lines in a 2D model, including the multidrug-resistant sublines. The peptaibols influenced the size and compactness of the cell lines in a 3D model. Our findings indicate the molecular basis of peptaibol production in T. atroviride O1 and the potential of its peptaibol-containing extracts as antimicrobial/anticancer agents.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003508
003      
CZ-PrNML
005      
20220127150145.0
007      
ta
008      
220113s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/molecules26196025 $2 doi
035    __
$a (PubMed)34641569
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Víglaš, Ján $u Institute of Biochemistry and Microbiology, Faculty of Food and Chemical Technology, Slovak University of Technology in Bratislava, 812 37 Bratislava, Slovakia
245    10
$a Peptaibol-Containing Extracts of Trichoderma atroviride and the Fight against Resistant Microorganisms and Cancer Cells / $c J. Víglaš, S. Dobiasová, J. Viktorová, T. Ruml, V. Repiská, P. Olejníková, H. Gbelcová
520    9_
$a Fighting resistance to antibiotics and chemotherapeutics has brought bioactive peptides to the fore. Peptaibols are short α-aminoisobutyric acid-containing peptides produced by Trichoderma species. Here, we studied the production of peptaibols by Trichoderma atroviride O1 and evaluated their antibacterial and anticancer activity against drug-sensitive and multidrug-resistant bacterium and cancer cell lines. This was substantiated by an analysis of the activity of the peptaibol synthetase-encoding gene. Atroviridins, 20-residue peptaibols were detected using MALDI-TOF mass spectrometry. Gram-positive bacteria were susceptible to peptaibol-containing extracts of T. atroviride O1. A synergic effect of extract constituents was possible, and the biolo-gical activity of extracts was pronounced in/after the peak of peptaibol synthetase activity. The growth of methicillin-resistant Staphylococcus aureus was reduced to just under 10% compared to the control. The effect of peptaibol-containing extracts was strongly modulated by the lipoteichoic acid and only slightly by the horse blood serum present in the cultivation medium. Peptaibol-containing extracts affected the proliferation of human breast cancer and human ovarian cancer cell lines in a 2D model, including the multidrug-resistant sublines. The peptaibols influenced the size and compactness of the cell lines in a 3D model. Our findings indicate the molecular basis of peptaibol production in T. atroviride O1 and the potential of its peptaibol-containing extracts as antimicrobial/anticancer agents.
650    _2
$a zvířata $7 D000818
650    _2
$a antibakteriální látky $x farmakologie $7 D000900
650    _2
$a protinádorové látky $x farmakologie $7 D000970
650    _2
$a nádorové buněčné linie $7 D045744
650    12
$a bakteriální léková rezistence $7 D024881
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fungální proteiny $x metabolismus $7 D005656
650    _2
$a koně $7 D006736
650    _2
$a lidé $7 D006801
650    _2
$a Hypocreales $x enzymologie $x metabolismus $7 D006999
650    _2
$a ligasy $x metabolismus $7 D008025
650    _2
$a MFC-7 buňky $7 D061986
650    _2
$a methicilin rezistentní Staphylococcus aureus $x účinky léků $7 D055624
650    _2
$a nádory $x farmakoterapie $7 D009369
650    _2
$a peptaiboly $x analýza $x metabolismus $x farmakologie $7 D054848
650    _2
$a spektrometrie hmotnostní - ionizace laserem za účasti matrice $7 D019032
655    _2
$a časopisecké články $7 D016428
700    1_
$a Dobiasová, Simona $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic
700    1_
$a Viktorová, Jitka $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic
700    1_
$a Ruml, Tomáš $u Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, 166 28 Prague, Czech Republic
700    1_
$a Repiská, Vanda $u Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia
700    1_
$a Olejníková, Petra $u Institute of Biochemistry and Microbiology, Faculty of Food and Chemical Technology, Slovak University of Technology in Bratislava, 812 37 Bratislava, Slovakia
700    1_
$a Gbelcová, Helena $u Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University in Bratislava, 813 72 Bratislava, Slovakia
773    0_
$w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 26, č. 19 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34641569 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127150141 $b ABA008
999    __
$a ok $b bmc $g 1751070 $s 1154657
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 26 $c 19 $e 20211004 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
GRA    __
$a VEGA-1/0697/18 $p Grant Agency of Ministry of Education, Science, Research and Sport of the Slovak Republic
GRA    __
$a 22010090 $p International Visegrad Fund
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...